109 related articles for article (PubMed ID: 3382239)
41. [Liver metastases from breast cancer--clinical features and treatment].
Masuda N; Yayoi E; Nakano Y; Monden T; Okamura J
Gan To Kagaku Ryoho; 1998 Jul; 25(9):1406-11. PubMed ID: 9703840
[TBL] [Abstract][Full Text] [Related]
42. Weekly dose adriamycin as first line chemotherapy in advanced breast cancer.
Jönsson PE; Malmberg M; Ericsson M; Ryden S
Anticancer Res; 1991; 11(2):877-9. PubMed ID: 2064346
[TBL] [Abstract][Full Text] [Related]
43. [Evaluation of intra-arterial infusion chemotherapy for advanced gastric cancer].
Kosaka T; Ueshige N; Sugaya J; Nakano Y; Akiyama T; Tomita F; Saito H; Kita I; Takashima S
Gan To Kagaku Ryoho; 1998 Jul; 25(9):1288-91. PubMed ID: 9703810
[TBL] [Abstract][Full Text] [Related]
44. [A randomized controlled study of (2'' R)-4'-O-tetrahydropyranyladriamycin and adriamycin in combination with cyclophosphamide and 5-fluorouracil in the treatment of advanced and recurrent breast cancer].
Abe O; Tominaga T; Enomoto K; Abe R; Iino Y; Koyama H; Fujimoto M; Nomura Y; Tanaka T
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2160-8. PubMed ID: 3717960
[TBL] [Abstract][Full Text] [Related]
45. [Neoadjuvant intra-arterial infusion chemotherapy for the treatment of locally advanced breast cancer with remote metastases].
Nakagawa H; Takatsuka Y; Shin E; Mishima H; Tono T; Tamaki Y; Yagyu T; Kobayashi K; Kikkawa N
Gan To Kagaku Ryoho; 1994 Sep; 21(13):2274-7. PubMed ID: 7944458
[TBL] [Abstract][Full Text] [Related]
46. [Neoadjuvant intraarterial chemotherapy with dose intensification in locally advanced breast cancer].
Takatsuka Y; Shin E; Fukuda K; Mishima H; Tono T; Yagyuu T; Kobayashi K; Kikkawa N
Gan To Kagaku Ryoho; 1995 Sep; 22(11):1546-8. PubMed ID: 7574755
[TBL] [Abstract][Full Text] [Related]
47. [Intraarterial high-dose adriamycin for patients with skeletal or soft tissue sarcoma].
Yoh S; Takagishi N; Iwasaki H; Eimoto T; Ono Y; Okasaki M
Gan No Rinsho; 1983 Aug; 29(10):1263-73. PubMed ID: 6632206
[TBL] [Abstract][Full Text] [Related]
48. [Clinical evaluation of adriamycin ointment in advanced or local recurrent breast cancer].
Shimizu S; Katayama K; Matsukawa H; Gotoh H; Matsumoto A; Yokoyama H; Suda T; Gotoh H; Arita M; Jojima T
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):590-2. PubMed ID: 3954381
[TBL] [Abstract][Full Text] [Related]
49. Intra-arterial infusion chemotherapy with 5-fluorouracil and cisplatin in advanced pancreatic cancer: a feasibility study.
Sasada T; Denno R; Tanaka T; Kanai M; Mizukami Y; Kohno S; Takabayashi A
Am J Clin Oncol; 2008 Feb; 31(1):71-8. PubMed ID: 18376231
[TBL] [Abstract][Full Text] [Related]
50. Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival.
Cance WG; Carey LA; Calvo BF; Sartor C; Sawyer L; Moore DT; Rosenman J; Ollila DW; Graham M
Ann Surg; 2002 Sep; 236(3):295-302; discussion 302-3. PubMed ID: 12192316
[TBL] [Abstract][Full Text] [Related]
51. [Clinical study of comparison of CAF regimen and TP regimen in treatment of advanced breast cancer].
Lin XG; Xie DR; Yao HR; Li ZH; Jiang ZM; Liu TH
Ai Zheng; 2003 Apr; 22(4):411-4. PubMed ID: 12704001
[TBL] [Abstract][Full Text] [Related]
52. Intra-arterial chemotherapy: a safe treatment for elderly patients with locally advanced breast cancer.
Pacetti P; Mambrini A; Paolucci R; Sanguinetti F; Palmieri B; Della Seta R; Muttini MP; Fiorentini G; Cantore M
In Vivo; 2006; 20(6A):761-4. PubMed ID: 17203763
[TBL] [Abstract][Full Text] [Related]
53. Modulation of molecular marker expression by induction chemotherapy in locally advanced breast cancer: correlation with the response to therapy and the expression of MDR1 and LRP.
Schneider J; Lucas R; Sánchez J; Ruibal A; Tejerina A; Martín M
Anticancer Res; 2000; 20(6B):4373-7. PubMed ID: 11205274
[TBL] [Abstract][Full Text] [Related]
54. Effect of concurrent intra-arterial infusion of platinum drugs for patients with stage III or IV uterine cervical cancer treated with radical radiation therapy.
Onishi H; Yamaguchi M; Kuriyama K; Tsukamoto T; Ishigame K; Ichikawa T; Aoki S; Yoshikawa T; Araki T; Nambu A; Araki T; Hashi A; Yasumizu T; Hoshi K; Ito H
Cancer J Sci Am; 2000; 6(1):40-5. PubMed ID: 10696738
[TBL] [Abstract][Full Text] [Related]
55. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
56. Locoregional recurrence of breast cancer: a retrospective comparison of treatment methods.
Skowronek J; Piotrowski T
Neoplasma; 2002; 49(6):426-31. PubMed ID: 12584593
[TBL] [Abstract][Full Text] [Related]
57. [Effective transarterial neoadjuvant chemotherapy with paclitaxel (TXL) in a case of locally advanced breast cancer].
Koga Y; Ohchi T; Kudo S; Ogata K; Nakamura T; Ishiodori H; Ochiai T; Muranaka T; Ishihara A
Gan To Kagaku Ryoho; 2003 Feb; 30(2):255-8. PubMed ID: 12610875
[TBL] [Abstract][Full Text] [Related]
58. [Adriamycin--breast cancer].
Nomura Y
Gan To Kagaku Ryoho; 1996 Dec; 23(14):1911-5. PubMed ID: 8978796
[TBL] [Abstract][Full Text] [Related]
59. Amonafide: An active agent in the treatment of previously untreated advanced breast cancer--a cancer and leukemia group B study (CALGB 8642).
Costanza ME; Berry D; Henderson IC; Ratain MJ; Wu K; Shapiro C; Duggan D; Kalra J; Berkowitz I; Lyss AP
Clin Cancer Res; 1995 Jul; 1(7):699-704. PubMed ID: 9816035
[TBL] [Abstract][Full Text] [Related]
60. A randomised phase II study of two different schedules of pegylated liposomal doxorubicin in metastatic breast cancer (EORTC-10993).
Coleman RE; Biganzoli L; Canney P; Dirix L; Mauriac L; Chollet P; Batter V; Ngalula-Kabanga E; Dittrich C; Piccart M
Eur J Cancer; 2006 May; 42(7):882-7. PubMed ID: 16520033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
